Skip to main content

AI news

Multiply Labs raises $75 million for robotic biomanufacturing

Multiply Labs announced a $75 million Series B led by Patrick Soon-Shiong with NantWorks, bringing total capital raised above $100 million. It plans to expand robotic manufacturing for cell, gene and other biologic therapies. The company’s cost and throughput figures are its own claims, and the round is financing, not a valuation or proof of clinical scale.

Multiply Labs

Series B financing

Funding & Deals

Published (date only)

1 source

Primary source · Multiply Labs · October 7, 2026

Opens Multiply Labs in a new tab. Read it there before you rely on the summary above.

Read the original

Free, email only

Unlock the full brief free.

  • What to check before you trust this story, written down
  • Each verified source, with why it matters and who published it
  • A note whenever a source has been withdrawn
  • Thirty days of stories to browse, not seven

This is not an account: there is no password, and the unlock is a cookie in this browser. You also join the Rise Productive newsletter from Demetri Panici, about once a week: what I built and what changed in AI. We'll email you a link to confirm, and you can unsubscribe in one click. The same signup unlocks every free tool on the site. How your email is handled.

Already subscribed? Enter the same email to unlock this browser. You won't be signed up twice.